DNA immunization as a technology platform for monoclonal antibody induction - Test2 - elhamkhani - TriplyDB

DNA immunization as a technology platform for monoclonal antibody induction

DNA immunization as a technology platform for monoclonal antibody induction

http://www.wikidata.org/entity/Q26751432

about

Opportunities for therapeutic antibodies directed at G-protein-coupled receptors.Characterization of Monoclonal Antibodies against HA Protein of H1N1 Swine Influenza Virus and Protective Efficacy against H1 Viruses in Mice.Evaluation of Immune Responses Induced by GRA7 and ROP2 Genes by DNA Vaccine Cocktails Against Acute Toxoplasmosis in BALB/c Mice.Camelid Single-Domain Antibodies: Historical Perspective and Future Outlook.Codon optimization and improved delivery/immunization regimen enhance the immune response against wild-type and drug-resistant HIV-1 reverse transcriptase, preserving its Th2-polarity.Analysis of the effect of promoter type and skin pretreatment on antigen expression and antibody response after gene gun-based immunization.Prolonged in vivo expression and anti-tumor response of DNA-based anti-HER2 antibodies.The wide utility of rabbits as models of human diseases.Immunogenicity and protective efficacy against Treponema pallidum in New Zealand rabbits immunized with plasmid DNA encoding flagellin One Group's Historical Reflections on DNA Vaccine Development

P2860

Q39433833-FEB3E677-F01D-41DF-AF92-E6874C79E028 Q40091003-2214F757-8545-44A0-8772-324351D3F739 Q47121882-17822B59-477B-4681-B77E-DEEE7BF1225C Q47135878-A0FE599C-B8F5-436F-860B-A5B91B12EDE8 Q55154648-836E5EC7-39C3-435F-8443-46A2D66C58A4 Q55185636-D1F5E59C-CE4B-4058-A47B-F956495062CA Q55241055-240AF479-D8FD-4A84-AC5D-161F95B77585 Q55250836-27DDDBB7-CCCC-4BFA-A278-53D38AF4B84F Q58594624-7EB91D96-B1B3-41ED-BA2B-BEA151DB3196 Q58731456-305232B8-BED7-400E-978F-2491DBDC0573

P2860

DNA immunization as a technology platform for monoclonal antibody induction

http://www.wikidata.org/entity/Q26751432

description

2016 nî lūn-bûn

@nan

2016 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

DNA immunization as a technology platform for monoclonal antibody induction

@ast

DNA immunization as a technology platform for monoclonal antibody induction

@en

DNA immunization as a technology platform for monoclonal antibody induction

@nl

type

label

DNA immunization as a technology platform for monoclonal antibody induction

@ast

DNA immunization as a technology platform for monoclonal antibody induction

@en

DNA immunization as a technology platform for monoclonal antibody induction

@nl

prefLabel

DNA immunization as a technology platform for monoclonal antibody induction

@ast

DNA immunization as a technology platform for monoclonal antibody induction

@en

DNA immunization as a technology platform for monoclonal antibody induction

@nl

P1433

Q26751432-901F3EDC-A927-4E78-BF33-B2FFA257CE24

P1476

Q26751432-5E05FD75-744E-456A-A148-7C540595E8F9

P2093

Q26751432-2CAC90C7-D3D0-4CF4-8790-256D397213E2

Q26751432-6F0D3CB1-EE23-469D-9C4E-F5297E8303ED

Q26751432-6F5575F5-A924-4C51-BBC5-A7289BE9F762

P275

Q26751432-FE1F9D0D-96CC-4689-8DED-A8D3E65C430F

P2860

Q26751432-01C61A37-52B7-4F30-8911-C109950509EE

Q26751432-05462985-927B-4878-A43F-28090D7B0A4B

Q26751432-0B3C08E8-8A2A-4ED5-8C01-5FB696B2FFCE

Q26751432-0BBF39E6-EDF3-4EF6-9FAE-BD55B68AA588

Q26751432-0E67B3B8-F5A9-4811-A7E3-5585041644AE

Q26751432-115AD3BD-A964-4A68-93D1-0F38D5E16B65

Q26751432-1DAE1CBD-F89F-43F1-8805-18B73C5F73E2

Q26751432-22682031-42BC-4F4D-9152-A5B8FCF4E3A1

Q26751432-254206BB-AFE5-45EC-96C3-7CC288D111E8

Q26751432-3652C4A9-20F1-47AC-86E0-579DAA155BDA

P2888

Q26751432-483A4FC5-9839-41A4-8FB4-8411AC997DE9

P304

Q26751432-3133D7D7-A984-4234-9D89-B5278B8DD948

P31

Q26751432-C86E40FB-0058-4580-8879-722B423B420D

Q26751432-E0971427-346C-4B5D-8B21-D2F6F4D5BBA9

P3181

Q26751432-82EC178B-2D75-4091-BD23-AF19919C4CD0

P356

Q26751432-100E2AFA-707C-44B8-94D6-9242F0DB81CC

P407

Q26751432-A6C4A292-6870-4382-AD8E-BA16D0524123

P433

Q26751432-183B3E00-F4E1-41AA-8FFF-3D4B3773074A

P478

Q26751432-0FCE0D24-B6E8-4336-B6B7-F34B7041A4E2

P577

Q26751432-498FD653-0C37-43CF-949F-F25416A8D93E

P5875

Q26751432-DF07AB7D-384F-4ABF-9B7F-0709CFCE1165

P6179

Q26751432-AF1836EE-187B-42CF-980C-6E369E8F957B

P698

Q26751432-C45E101B-1ABD-4CFB-ADBB-D3A220199E50

P921

Q26751432-15911C49-DA9E-479B-80C0-7A5DD7844735

Q26751432-15932268-696F-4F44-B3CB-4ED2021F2A44

Q26751432-2E51A233-2E37-4AB4-B210-17396DAB888E

Q26751432-8E9D4FDF-52A8-49EA-BB49-37B7E8D85520

Q26751432-8F301C0C-2DF9-4FCD-9A62-94210EC7F80D

Q26751432-9C753BF2-337D-4D59-8AB3-8820BCF323A7

Q26751432-FC589859-0BE0-4562-B44F-0DF04252F34C

Q26751432-FEEAEE9A-3022-4020-8B06-FC990083AB64

P932

Q26751432-F91AE541-D8F9-4CB4-B806-C61DBC6BE6C4

P3181

P356

P1433

Emerging microbes & infections

P1476

DNA immunization as a technology platform for monoclonal antibody induction

@en

P2093

Shan Lu

http://www.w3.org/2001/XMLSchema#string

Shixia Wang

http://www.w3.org/2001/XMLSchema#string

Shuying Liu

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations

Identification of hepatitis G virus particles in human serum by E2-specific monoclonal antibodies generated by DNA immunization

Monoclonal antibodies against human aspartyl (asparaginyl) beta-hydroxylase developed by DNA immunization

A novel monoclonal anti-CD81 antibody produced by genetic immunization efficiently inhibits Hepatitis C virus cell-cell transmission

Influenza H5 hemagglutinin DNA primes the antibody response elicited by the live attenuated influenza A/Vietnam/1203/2004 vaccine in ferrets

Heterologous HA DNA vaccine prime--inactivated influenza vaccine boost is more effective than using DNA or inactivated vaccine alone in eliciting antibody responses against H1 or H3 serotype influenza viruses.

Profiles of human serum antibody responses elicited by three leading HIV vaccines focusing on the induction of Env-specific antibodies.

Antibody responses elicited through homologous or heterologous prime-boost DNA and protein vaccinations differ in functional activity and avidity.

Enhanced immunogenicity of gp120 protein when combined with recombinant DNA priming to generate antibodies that neutralize the JR-FL primary isolate of human immunodeficiency virus type 1.

In vivo electroporation and non-protein based screening assays to identify antibodies against native protein conformations.

P2888

P304

e33

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2464273

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/EMI.2016.27

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2016-04-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

300374809

http://www.w3.org/2001/XMLSchema#string

P6179

1023348415

http://www.w3.org/2001/XMLSchema#string

P698

27048742

http://www.w3.org/2001/XMLSchema#string

P921

monoclonal antibody

recombinant protein

preventive health services

biomedical investigative technique

P932

4855071

http://www.w3.org/2001/XMLSchema#string